Renaissance Technologies LLC / VRTX
Renaissance Technologies LLC’s Vertex Pharmaceuticals Inc Position
Does Renaissance Technologies LLC own Vertex Pharmaceuticals Inc (VRTX)? Yes — 421.7K shares worth $188M (+0.29% of its 13F portfolio) as of Q1 2026, down from 505.0K shares the prior filed quarter.
Position Value
$188M
Q1 2026
Shares
421.7K
% of Portfolio
+0.29%
Quarters Held
26
currently held
Position History VRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 421.7K | $188M | +0.29% |
| Q4 2025 | 505.0K | $229M | +0.36% |
| Q3 2025 | 735.9K | $288M | +0.38% |
| Q2 2025 | 1.00M | $447M | +0.60% |
| Q1 2025 | 1.17M | $568M | +0.86% |
| Q4 2024 | 1.40M | $563M | +0.83% |
| Q3 2024 | 1.63M | $759M | +1.14% |
| Q2 2024 | 1.57M | $734M | +1.25% |
| Q1 2024 | 1.58M | $660,660 | +1.04% |
| Q4 2023 | 1.59M | $647,642 | +1.00% |
| Q3 2023 | 1.66M | $578,670 | +0.99% |
| Q2 2023 | 1.27M | $447,686 | +0.65% |
| Q1 2023 | 1.40M | $440,384 | +0.58% |
| Q4 2022 | 2.25M | $648,817 | +0.89% |
| Q3 2022 | 2.14M | $619M | +0.88% |
| Q2 2022 | 1.76M | $496M | +0.59% |
| Q1 2022 | 1.71M | $446M | +0.52% |
| Q4 2021 | 1.63M | $357M | +0.44% |
| Q3 2021 | 1.89M | $343M | +0.44% |
| Q2 2021 | 2.28M | $459M | +0.57% |
| Q1 2021 | 2.40M | $516M | +0.64% |
| Q4 2020 | 3.58M | $845M | +0.92% |
| Q3 2020 | 5.21M | $1.4B | +1.41% |
| Q2 2020 | 5.78M | $1.7B | +1.45% |
| Q1 2020 | 6.86M | $1.6B | +1.59% |
| Q4 2019 | 7.08M | $1.5B | +1.19% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Renaissance Technologies LLC’s full portfolio or all institutional holders of VRTX.